期刊文献+

浅谈“七损八益”与三阴性乳腺癌雌激素受体、雄激素受体的表达 被引量:2

Discussion on Expressions of ER and AR in Triple-Negative Breast Cancer with Seven Ills and Eight Benefits
原文传递
导出
摘要 乳腺癌是我国女性发病率第一的恶性肿瘤[1],其中三阴性乳腺癌较其他类型乳腺癌相比,具有治疗棘手、预后更差的特点。"七损八益"是以阴阳损益之道来谈保身长全的理论思想。文章将结合"七损八益"的观点,从其损益转化的角度来讨论三阴性乳腺癌的治疗方法。其中以七损对应三阴性乳腺癌雌激素受体阴性,八益为应用雄激素受体治疗三阴性乳腺癌的手段。试以《内经》"七损八益"理论来探讨三阴性乳腺癌的关系,为研究治疗乳腺癌提供更多的思路。 Breast cancer is a malignant tumor with the highest incidence among Chinese women[1].Among them,triple-negative breast cancer is more difficult to treat and has worse prognosis than other types of breast cancer.The theory of“seven ills and eight benefits”is based on the theory of Yin and Yang.In this paper,the treatment of triple-negative negative breast cancer is discussed from the perspective of benefits and loss transformation.Among them,seven ills correspond to triple-negative breast cancer estrogen receptor being negative and eight benefits are the androgen receptor treatment of triple-negative breast cancer.This paper attempts to explore the relationship between triple-negative breast cancer by using the theory of“seven ills and eight benefits”in Internal Classic,which provides more ideas for the research and treatment of breast cancer.
作者 朱中博 杨硕 李康乐 窦建卫 ZHU Zhongbo;YANG Shuo;LI Kangle;DOU Jianwei(Basic Medical College of Gansu University of Traditional Chinese Medicine,Lanzhou 730000,Gansu,China;Xi'an Jiaotong University Medical School,Xi'an 710061,Shaanxi,China)
出处 《辽宁中医杂志》 CAS 2020年第2期96-97,共2页 Liaoning Journal of Traditional Chinese Medicine
基金 国家自然科学基金(81573983,81873311)。
关键词 七损八益 三阴性乳腺癌 雌激素受体 雄激素受体 seven ills and eight benefits triple-negative breast cancer estrogen receptor androgen receptor
  • 相关文献

参考文献10

二级参考文献46

  • 1池田知久,牛建科.马王堆汉墓帛书《周易》之《要》篇释文(下)[J].周易研究,1997(3):8-21. 被引量:26
  • 2井海明.简论帛书《易传》中的卦气思想[J].周易研究,2002(4):45-49. 被引量:3
  • 3蒋应时.中医养生理论的核心与道家养生思想[J].中医研究,1994,7(4):3-4. 被引量:6
  • 4顾植山,陈曦.“七损八益”仅仅是房中术吗?[J].中医药文化,2006,1(2):33-36. 被引量:16
  • 5Rakha EA,El-Sayed ME,Green AR,et al.Prognostic markers intriple-negative breast cancer[J].Cancer,2007,109:25-32.
  • 6Morris GJ,Naidu S,Topham AK,et al.Differences in breastcarcinoma characteristics in newly diagnosed african-americanand caucasian patients:a single-institution compilation comparedwith the national cancer institute's surveillance,epidemiology,and end results database[J].Cancer,2007,110:876-884.
  • 7Reis-Filho JS,Tutt AN.Triple negative tumours:a critical re-view[J].Histopathology,2008,52:108-118.
  • 8Kim MJ,Ro JY,Ahn SH,et al.Clinicopathologic significance ofthe basal-like subtype of breast cancer:a comparison with hor-mone receptor and Her2/neu-overexpressing phenotypes[J].Hum Pathol,2006,37:1217-1226.
  • 9Sasa M,Bando Y,Takahashi M,et al.Screening for basalmarker expression is necessary for decision of therapeutic strategyfor triple-negative breast cancer[J].J Surg Oncol,2008,97:30-34.
  • 10Tischkowitz M,Brunet JS,Bégin LR et al.Use of immunohisto-chemical markers can refine prognosis in triple negative breastcancer[J].BMC Cancer,2007,7:134.

共引文献67

同被引文献23

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部